nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Gemifloxacin—Visual impairment—Betamethasone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Visual impairment—Dexamethasone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Gemifloxacin—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Vertigo—Prednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Syncope—Prednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Eye disorder—Betamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Back pain—Triamcinolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Gemifloxacin—Angiopathy—Dexamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Gemifloxacin—Angiopathy—Betamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Gemifloxacin—Haemoglobin—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Haemorrhage—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Gemifloxacin—Vertigo—Triamcinolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Gemifloxacin—Syncope—Triamcinolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Gemifloxacin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Gemifloxacin—Syncope—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Oedema—Prednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Shock—Prednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Gemifloxacin—Myalgia—Triamcinolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Myalgia—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Eye disorder—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Flushing—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Dry mouth—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Gemifloxacin—Angiopathy—Prednisone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Gemifloxacin—Immune system disorder—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Oedema—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Vertigo—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Vertigo—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Syncope—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Syncope—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gemifloxacin—Shock—Triamcinolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Insomnia—Prednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Shock—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Tachycardia—Triamcinolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Mental disorder—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Myalgia—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Myalgia—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Pain—Prednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Oedema—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Oedema—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Insomnia—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Anaemia—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Shock—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Shock—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Tachycardia—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Tachycardia—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Vertigo—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Syncope—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Anorexia—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Anorexia—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Urticaria—Prednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Fatigue—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Pain—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Myalgia—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Arthralgia—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Insomnia—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Insomnia—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Urticaria—Triamcinolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Oedema—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Decreased appetite—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Fatigue—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Fatigue—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Shock—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Pain—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Pain—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Skin disorder—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Anorexia—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Urticaria—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Urticaria—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Dizziness—Prednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Asthenia—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Insomnia—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Pruritus—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gemifloxacin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gemifloxacin—Dyspepsia—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Decreased appetite—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Rash—Prednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Fatigue—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Headache—Prednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Constipation—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Dizziness—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Asthenia—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Asthenia—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Nausea—Prednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Pruritus—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Pruritus—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Vomiting—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Rash—Triamcinolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Rash—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Urticaria—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Headache—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Headache—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Abdominal pain—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Body temperature increased—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Dizziness—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Dizziness—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Nausea—Triamcinolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Nausea—Methylprednisolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Gemifloxacin—Vomiting—Betamethasone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Gemifloxacin—Vomiting—Dexamethasone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000989	0.000989	CcSEcCtD
Gemifloxacin—Rash—Dexamethasone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Gemifloxacin—Rash—Betamethasone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Gemifloxacin—Dermatitis—Betamethasone—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
Gemifloxacin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000982	0.000982	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Gemifloxacin—Headache—Dexamethasone—psoriatic arthritis	0.000979	0.000979	CcSEcCtD
Gemifloxacin—Headache—Betamethasone—psoriatic arthritis	0.000979	0.000979	CcSEcCtD
Gemifloxacin—Asthenia—Prednisone—psoriatic arthritis	0.000976	0.000976	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—psoriatic arthritis	0.000973	0.000973	CcSEcCtD
Gemifloxacin—Pruritus—Prednisone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Gemifloxacin—Diarrhoea—Prednisone—psoriatic arthritis	0.000931	0.000931	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00093	0.00093	CcSEcCtD
Gemifloxacin—Nausea—Dexamethasone—psoriatic arthritis	0.000928	0.000928	CcSEcCtD
Gemifloxacin—Nausea—Betamethasone—psoriatic arthritis	0.000928	0.000928	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—psoriatic arthritis	0.000904	0.000904	CcSEcCtD
Gemifloxacin—Dizziness—Prednisone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000899	0.000899	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000899	0.000899	CcSEcCtD
Gemifloxacin—Vomiting—Prednisone—psoriatic arthritis	0.000865	0.000865	CcSEcCtD
Gemifloxacin—Rash—Prednisone—psoriatic arthritis	0.000858	0.000858	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisone—psoriatic arthritis	0.000857	0.000857	CcSEcCtD
Gemifloxacin—Headache—Prednisone—psoriatic arthritis	0.000853	0.000853	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—psoriatic arthritis	0.000816	0.000816	CcSEcCtD
Gemifloxacin—Nausea—Prednisone—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—psoriatic arthritis	0.000805	0.000805	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000778	0.000778	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—psoriatic arthritis	0.000752	0.000752	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—psoriatic arthritis	0.000723	0.000723	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—psoriatic arthritis	0.000717	0.000717	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—psoriatic arthritis	0.000716	0.000716	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
